Experimental cell therapy targets Tough-to-Treat blood cancer

This study is testing an experimental cell therapy called S101 for adults with a specific type of aggressive blood cancer (T-cell leukemia/lymphoma) that has come back or not responded to other treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target a protein called CD7 on the cancer cells, and then infuse them back. The main goal is to see if this one-time treatment is effective and safe for these patients who have few other options.